Please check your internet connection and try again.
# Acetylcysteine
## Overview
Acetylcysteine is a mucolytic agent and an antidote for acetaminophen overdose. It works by breaking disulfide bonds in mucoproteins, decreasing mucus viscosity, and by replenishing glutathione stores depleted by acetaminophen toxicity.
## Primary Indications
* **Acetaminophen Overdose:** To prevent or reduce liver damage.
* **Mucolytic Agent:** To thin and loosen mucus in respiratory conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and bronchitis.
## Adult Dosing
### Acetaminophen Overdose
The most common protocol involves an initial bolus followed by a continuous infusion.
* **Initial Loading Dose:** 150 mg/kg intravenously (IV) over 60 minutes.
* **Second Dose:** 50 mg/kg IV over the next 60 minutes.
* **Third Dose:** 100 mg/kg IV over the subsequent 15 hours.
Total duration of treatment is typically 20-21 hours. Dosing may be adjusted based on serum acetaminophen levels and clinical presentation. Some protocols may use higher initial doses.
### Mucolytic Agent
* **Nebulized:** 1-10 mL of a 20% solution or 2-20 mL of a 10% solution, every 2-6 hours as needed.
* **Oral (Effervescent Tablets/Granules):** Typically 200 mg to 600 mg two to three times daily.
* **Intravenous (IV):** Not typically used for mucolytic indications; reserved for overdose.
## Pediatric Dosing
### Acetaminophen Overdose
Dosing is weight-based and follows the same protocol as adults:
* **Initial Loading Dose:** 150 mg/kg IV over 60 minutes.
* **Second Dose:** 50 mg/kg IV over the next 60 minutes.
* **Third Dose:** 100 mg/kg IV over the subsequent 15 hours.
Maximum doses should be calculated based on patient weight.
### Mucolytic Agent
* **Nebulized:**
* Infants and children up to 12 years: 1-2 mL of a 20% solution or 2-4 mL of a 10% solution, every 2-6 hours.
* Children over 12 years: Same as adult nebulized dosing.
* **Oral:** Dosing varies by age and product formulation. Consult specific product labeling.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustment is usually necessary for the oral or nebulized forms. For IV acetaminophen overdose, cautious use may be warranted, but typically the benefits outweigh risks.
* **Hepatic Impairment:** No specific dose adjustment is usually necessary for the oral or nebulized forms. For IV acetaminophen overdose, monitoring is crucial due to increased risk of hepatotoxicity.
## Contraindications
* Known hypersensitivity to acetylcysteine.
* Active gastrointestinal bleeding (for oral formulations).
## Adverse Effects
* **Most Common (Nebulized):** Bronchospasm, bronchoconstriction, precipitation of mucus. Nausea, vomiting, stomatitis.
* **Most Common (IV - Acetaminophen Overdose):** Anaphylactoid reactions (rash, pruritus, urticaria, angioedema, bronchospasm, dyspnea, hypotension), ranging from mild to severe. Nausea and vomiting are also common. Flushing, headache.
## Key Drug Interactions
* **Activated Charcoal:** May reduce the absorption of oral acetylcysteine.
* **Nitroglycerin:** Concomitant use may potentiate the hypotensive effect and vasodilation of nitroglycerin.
* **Antitussives:** May mask the symptom of increased bronchial secretions that may require clearance.
## Monitoring
* **Acetaminophen Overdose (IV):**
* Serum acetaminophen levels at appropriate time points (e.g., 4 hours post-ingestion, and at 12, 24, 36, 48 hours).
* Liver function tests (ALT, AST, bilirubin, INR) regularly, especially if levels are elevated or ingestion history is unclear.
* Renal function and electrolytes.
* Vital signs and signs of anaphylactoid reactions.
* **Mucolytic (Oral/Nebulized):**
* Respiratory status, effectiveness in thinning secretions.
* Signs of bronchospasm.
## Clinical Pearls
* For IV acetaminophen overdose, initiating acetylcysteine as soon as possible, even before serum levels are available, is crucial if overdose is suspected and ingestion occurred within the last 8-24 hours.
* Dilute IV acetylcysteine to a maximum concentration of 12 mg/mL to reduce the risk of phlebitis and local reactions.
* Pretreatment with an H1 and/or H2 antagonist may be considered to reduce the incidence and severity of anaphylactoid reactions with IV acetylcysteine.
* Nebulized acetylcysteine can cause bronchospasm, especially in patients with asthma. Consider co-administration with a bronchodilator.
* The characteristic sulfurous ("rotten egg") odor of acetylcysteine is unpleasant but does not affect its efficacy.
***
This information is intended for healthcare professionals and does not replace the need to consult the official prescribing information and relevant clinical guidelines. Always verify current drug information before prescribing or dispensing.